Cyto-Sen Therapeutics, Inc. — Form D
Cyto-Sen Therapeutics, Inc. of ORLANDO, FL, a company, filed a Form D exempt-offering notice with the SEC on 2016-12-13. The offering totals $856K, of which $800K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-12-13
- Form: D
- Accession: 0001691483-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $856K
- Amount sold: $800K
- Remaining: $56K
- Minimum investment: $50K
- Investors: 6
- Date of first sale: 2016-12-01
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-276137
Issuer
- Name: Cyto-Sen Therapeutics, Inc.
- CIK: 0001691483
- Entity type: Corporation
- Jurisdiction: FLORIDA
- Incorporated: 2014
- Address: 3259 PROGRESS DRIVE, ORLANDO, FL, 32826
- Phone: 5104075383
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| Stefan O Ciurea | Director | Houston, TX |
| Dean Anthony Lee | Director | Canal Winchester, OH |
| Philip R McKee | Director | Frisco, TX |
More